Options for new CEO Strike price 2.87CAD, almost 500,000 shares, so he'll make money on the differential of the stock price over time. His interests are aligned.
Question for this board on Oncology: Does anyone have an idea of what new clinical data will show in the near future as mentioned on the Tuesdat call? Does anyone ascribe any value to Oncology or at what point will you?